Table 1 Characteristics of the Study Population
Characteristics | Group A (N = 34) | Group B (N = 33) | P |
|---|---|---|---|
Age (years) | 48 ± 6 | 51 ± 6 | 0.07 |
BMI (kg/m2) | 22.61 ± 2.51 | 23.52 ± 2.81 | 0.16 |
SBP (mm Hg) | 119.00 ± 11.54 | 120.84 ± 13.38 | 0.55 |
DBP (mm Hg) | 79.00 ± 7.38 | 81.16 ± 8.30 | 0.26 |
h (bpm) | 73.65 ± 4.29 | 73.84 ± 7.06 | 0.89 |
Cardiovascular history*, n (%) | |||
Hypertension | 9 (26.5%) | 11 (33.3%) | 0.53 |
Diabetes mellitus | 5 (14.7%) | 6 (18.2%) | 0.70 |
Medications, n (%) | |||
Statin | 7 (20.6%) | 4 (12.1%) | 0.51 |
Beta-blocker | 4 (11.4%) | 6 (16.7%) | 0.76 |
ACEI or ARB | 5 (14.7%) | 7 (21.2%) | 0.48 |
Calcium channel blocker | 7 (20.6%) | 8 (24.2%) | 0.72 |